Dr Pausins Low Dose Chewable Aspirin
NDC Package 71476-101-31

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Dr Pausins Low Dose Chewable Aspirin is a . Marketed by Achlis Laboratories, this product is identified by NDC 71476-101 and is authorized under FDA application part343.

Identification & Billing

NDC Package Code
71476-101-31
Package Description
3 BOTTLE in 1 CARTON / 36 TABLET, CHEWABLE in 1 BOTTLE (71476-101-36)
Product Code
71476-101
11-Digit Billing Format
71476010131

Clinical Specifications

Proprietary Name
Dr Pausins Low Dose Chewable Aspirin Cherry Flavor
Dosage Form
-

Regulatory & Marketing

Labeler Name
Achlis Laboratories
FDA Application #
part343
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
10-10-2017
End Marketing Date
11-30-2018
Listing Expiration
11-30-2018
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71476-101-31 identifies a specific commercial package of 3 bottle in 1 carton / 36 tablet, chewable in 1 bottle (71476-101-36) of Dr Pausins Low Dose Chewable Aspirin Cherry Flavor, labeled by Achlis Laboratories. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Achlis Laboratories on October 10, 2017. The current certification is valid through November 30, 2018.

How is this Achlis Laboratories product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71476010131. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
71476-101-31
11-Digit CMS (5-4-2)
71476-0101-31

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.